Active Ingredient History
Polydextrose is a synthetic polymer of glucose. It is a food ingredient classified as soluble fiber by the US FDA as well as Health Canada, as of April 2013. It is frequently used to increase the dietary fiber content of food, to replace sugar, and to reduce calories and fat content. It is a multi-purpose food ingredient synthesized from dextrose (glucose), plus about 10 percent sorbitol and 1 percent citric acid. Its E number is E1200. The FDA approved it in 1981. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acidosis (Phase 3)
Acute Coronary Syndrome (Phase 2)
Adolescent Behavior (Early Phase 1)
Air Travel (Phase 2/Phase 3)
Anesthesia (Phase 2/Phase 3)
Arrhythmias, Cardiac (Phase 1)
Arthritis (Phase 2/Phase 3)
Arthropathy, Neurogenic (Phase 2/Phase 3)
Back Pain (Phase 3)
Blood Pressure (Early Phase 1)
Body Weight (Phase 2)
Brain Injuries, Traumatic (Phase 1)
Breast Neoplasms (Phase 3)
Bursitis (Phase 4)
Carpal Tunnel Syndrome (Phase 3)
Colonic Diseases (Phase 4)
Constipation (Phase 2)
COVID-19 (Phase 3)
Critical Illness (Phase 2)
Dehydration (Phase 4)
Dermatitis, Atopic (Phase 3)
Diabetes, Gestational (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetes Mellitus, Type 2 (Phase 4)
Dietary Sugars (Phase 4)
Dronabinol (Early Phase 1)
Ehlers-Danlos Syndrome (Phase 3)
Exercise (Phase 4)
Female (Early Phase 1)
Fibrosis (Phase 4)
Gastroschisis (Phase 1)
Glucose Intolerance (Phase 2)
Healthy Volunteers (Phase 4)
Hepatitis, Alcoholic (Phase 2)
Hyperglycemia (Phase 2)
Hyperkalemia (Phase 4)
Hypernatremia (Phase 4)
Hypertension (Early Phase 1)
Hypoglycemia (Phase 2)
Hypokalemia (Phase 4)
Hyponatremia (Phase 4)
Influenza, Human (Phase 4)
Injections (Phase 4)
Insulin Resistance (Phase 2)
Intestinal Diseases (Phase 4)
Ischemic Stroke (Phase 2)
Kidney Failure, Chronic (Phase 2)
Liver Diseases (Phase 2/Phase 3)
Low Back Pain (Phase 3)
Myocardial Infarction (Phase 1)
Myocardial Reperfusion Injury (Phase 1)
Myofascial Pain Syndromes (Phase 4)
Obesity (Phase 4)
Osteoarthritis, Knee (Phase 4)
Pain (Phase 4)
Pancreatic Diseases (Phase 2/Phase 3)
Patient Satisfaction (Phase 3)
Peritoneal Dialysis (Phase 4)
Pharmacokinetics (Phase 4)
Physical Therapy Modalities (Phase 4)
Post-Dural Puncture Headache (Phase 4)
Postural Balance (Phase 4)
Prediabetic State (Phase 2)
Psychotic Disorders (Phase 2)
Renal Dialysis (Phase 2)
Reperfusion Injury (Phase 1)
Respiratory Distress Syndrome (Phase 2)
Respiratory Insufficiency (Phase 2)
Rotator Cuff Injuries (Phase 2/Phase 3)
Schizophrenia (Phase 2)
Sepsis (Phase 2)
Shock (Phase 3)
Shoulder Injuries (Phase 4)
Sodium (Phase 2)
Sprains and Strains (Phase 2)
Systemic Inflammatory Response Syndrome (Phase 4)
Temporomandibular Joint Disorders (Phase 2)
Tennis Elbow (Phase 4)
Water-Electrolyte Balance (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue